These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29589313)

  • 1. Proteomic Profiling for Colorectal Cancer Biomarker Discovery.
    Álvarez-Chaver P; De Chiara L; Martínez-Zorzano VS
    Methods Mol Biol; 2018; 1765():241-269. PubMed ID: 29589313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.
    Otero-Estévez O; De Chiara L; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Cubiella J; Hernández V; Martínez-Zorzano VS
    Sci Rep; 2016 May; 6():26703. PubMed ID: 27222072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of minute amount of colonic biopsies by enteroscopy sampling.
    Liu X; Xu Y; Meng Q; Zheng Q; Wu J; Wang C; Jia W; Figeys D; Chang Y; Zhou H
    Biochem Biophys Res Commun; 2016 Aug; 476(4):286-292. PubMed ID: 27230957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of putative colorectal cancer markers by applying PCA on the soluble proteome of tumors: NDK A as a promising candidate.
    Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; García-Lorenzo A; Páez de la Cadena M; Martínez-Zorzano VS
    J Proteomics; 2011 May; 74(6):874-86. PubMed ID: 21385632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
    Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
    Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
    You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
    J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics for discovery of candidate colorectal cancer biomarkers.
    Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
    World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
    de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
    Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer.
    Albrethsen J; Bøgebo R; Møller CH; Olsen JA; Raskov HH; Gammeltoft S
    Proteomics Clin Appl; 2012 Apr; 6(3-4):182-9. PubMed ID: 22532454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.
    Yao L; Lao W; Zhang Y; Tang X; Hu X; He C; Hu X; Xu LX
    J Proteome Res; 2012 Jun; 11(6):3281-94. PubMed ID: 22506683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.